Endotoxin, a constituent of Gram-negative bacteria, stimulates macrophages
to release Large quantities of tumor necrosis factor (TNF) and interleukin-
1 (IL-1), which can precipitate tissue injury and lethal shock (endotoxemia
). Antagonists of TNF and IL-1 have shown Limited efficacy in clinical tria
ls, possibly because these cytokines are early mediators in pathogenesis, H
ere a potential Late mediator of Lethality is identified and characterized
in a mouse model. High mobility group-1 (HMG-1) protein was found to be rel
eased by cultured macrophages more than 8 hours after stimulation with endo
toxin, TNF, or IL-1. Mice showed increased serum Levels of HMG-1 from 8 to
32 hours after endotoxin exposure. Delayed administration of antibodies to
HMG-1 attenuated endotoxin lethality in mice, and administration of HMG-1 i
tself was lethal. Septic patients who succumbed to infection had increased
serum HMG-1 levels, suggesting that this protein warrants investigation as
a therapeutic target.